SET SMS ALERT
BSE - No shares traded
High
397.30
Low
395.10
Laurus Labs Ltd.
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Nov 19, 15:42
399.30
2.50 (+0.63%)
VOLUME 1,034
AVERAGE VOLUME
| 5-Day | 3,174 |
| 10-Day | 3,080 |
| 30-Day | 29,445 |
VOLUME SHOCKER
| 5-Day | 3,174 |
| 10-Day | 3,080 |
| 30-Day | 29,445 |
Prev. Close
396.80
Open Price
397.55
Bid PRICE (QTY.)
399.30 (200)
Offer PRICE (Qty.)
404.95 (20)
Market
Depth
Depth
Market Depth (19 Nov 2018)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 7 | 395.05 | 403.90 | 5 |
| 1 | 395.00 | 404.95 | 20 |
| 10 | 394.00 | 405.00 | 25 |
| 10 | 392.20 | 406.00 | 25 |
| 1 | 391.05 | 409.00 | 1 |
| 2020 | Total | 850 | Total |
Buy Qty
2020
Sell QTY
850
Today's Low/High
393.25
403.90
52 Wk Low/High
330.30
579.25
L/U Price Band
317.45
476.15
LIVE
NSE
Nov 19, 15:56
400.95
1.80 (+0.45%)
VOLUME 55,168
AVERAGE VOLUME
| 5-Day | 43,660 |
| 10-Day | 43,707 |
| 30-Day | 71,088 |
VOLUME SHOCKER
| 5-Day | 43,660 |
| 10-Day | 43,707 |
| 30-Day | 71,088 |
Prev. Close
399.15
Open Price
395.10
Bid PRICE (QTY.)
400.95 (650)
Offer PRICE (Qty.)
0.00 (0)
- Quote
- CHARTS
- NEWS
- COMMENTS
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Track Laurus Labs on the go with the moneycontrol app
Action in Laurus Labs
-
52 Week Low
Laurus Labs has hit 52wk low of Rs 386.20 on NSE -
52 Week Low
Laurus Labs has hit 52wk low of Rs 414.40 on NSE -
52 Week Low
Laurus Labs has hit 52wk low of Rs 422.30 on BSE -
52 Week Low
Laurus Labs has hit 52wk low of Rs 425.00 on BSE -
52 Week Low
Laurus Labs has hit 52wk low of Rs 435.00 on BSE
Laurus Labs
Sentimeter
100%
BUY
100% of moneycontrol users recommend buying Laurus Labs.
What's your call on Laurus Labs today?
Read Investor view
Consolidated
MARKET CAP (Rs Cr)
4,250.02
P/E
37.71
BOOK VALUE (Rs)
139.34
DIV (%)
15.00%
Market Lot
1
INDUSTRY P/E
30.06
EPS (TTM)
10.59
P/C
17.84
PRICE/BOOK
2.87
DIV YIELD.(%)
0.38%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
COLLAPSE ALL
Top Trading Ideas
9 November 2018
buy UPL Nov Fut |
Entry Price (Rs) 732.00 |
Exit Price (Rs) 738.50 |
Gain (Rs) 7.00 |
buy LICHousingFin Nov Fut |
Entry Price (Rs) 434.15 |
Exit Price (Rs) 442.65 |
Gain (Rs) 9.00 |
Historic Prices & Simple Moving Averages
Simple Moving Averages
| Days | BSE | NSE |
| 30 | 379.78 | 379.58 |
| 50 | 401.16 | 401.04 |
| 150 | 447.28 | 447.29 |
| 200 | 465.25 | 465.38 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Laurus Labs
The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
News/Videos & Announcements
News
Announcements
Nov 01, 2018
Laurus Labs - Laurus Labs Press Release Of The Results Of The Quarter And Half Year Ended September 30, 2018.Videos
Stock Advice & Research Reports
Stock Advice
Research Reports
Financials
Income Statement
| Standalone | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
| Net Sales | 574.63 | 531.10 | 546.55 | 473.77 |
| Other Income | 10.51 | 2.58 | 5.01 | 9.80 |
| PBDIT | 75.16 | 78.29 | 114.44 | 86.62 |
| Net Profit | 17.63 | 15.93 | 46.35 | 35.89 |
Annual Report
Download in PDF format 2017
Balance Sheet
Mar'18
(In Rs Cr)
(In Rs Cr)
| Total Share Capital | 106.03 |
| Net Worth | 1,513.30 |
| Total Debt | 867.72 |
| Net Block | 1,447.69 |
| Investments | 51.74 |
| Total Assets | 2,381.02 |
Peers
Peer Comparison
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 530.55 | 2.11 | 678.80 | 434.80 | 127,296.17 |
| Aurobindo Pharm | 793.40 | 1.69 | 826.35 | 527.05 | 46,485.91 |
| Piramal Enter | 2359.00 | 0.75 | 3302.55 | 1796.75 | 43,095.26 |
| Cipla | 528.70 | -0.41 | 678.00 | 508.10 | 42,573.68 |
| Dr Reddys Labs | 2527.15 | 2.28 | 2687.45 | 1888.00 | 41,962.28 |
| More » | |||||
News on Peers & Sector
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
| Jun' 18 | Dec' 17 | Sep' 17 | Jun' 17 | |
| Promoter | 32.06 | 30.57 | 30.56 | 30.64 |
| Public (FII + DII) | 67.94 | 69.43 | 69.44 | 69.36 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
Mutual Funds Holding
| Scheme | No. of Shares |
| SBI Magnum Midcap Fund (G) | 1,215,494 |
| SBI Magnum Tax Gain Scheme (G) | 1,056,980 |
| Kotak Standard Multicap Fund - Regular Plan (G) | 770,641 |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Regular Plan (G) | 731,562 |
Company Information
REGISTERED OFFICE
Address
Plot No.21 & 18, Jawaharlal Nehru Pharma City,
,Parawada,
City
Vishakapatnam
State
Andhra Pradesh
Pin Code
531021
Tel. No.
0891-3061222
Fax No.
0891-3061270
Email:
Internet
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Karvy Selenium Tower B,
Plot No. 31-32, Gachibowl
City
Hyderabad - 500032
State
Telangana
Tel. No.
040-67162222, 67161500
Fax No.
040-23420814, 23001153
Email:
Internet
MANAGEMENT
Name
Designation
M Venu Gopala Roa
Non Executive Chairman
Satyanarayana Chava
WholeTime Director & CEO
Venkata Ravi Kumar Vantaram
Executive Director & CFO
Chandrakanth Chereddi
Executive Director
Narendra Ostawal
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT
Radico Khaitan Recommended on Sep 28th 2017
Recommended price 154.00 | Peak from reco 500.00 225.63%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Laurus Labs
Laurus Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 4,250.02 crore.
The company management includes M Venu Gopala Roa - Non Executive Chairman, Satyanarayana Chava - WholeTime Director & CEO, Venkata Ravi Kumar Vantaram - Executive Director & CFO, Chandrakanth Chereddi - Executive Director, Narendra Ostawal - Director, Aruna Rajendra Bhinge - Independent Director, Rajesh Koshy Chandy - Independent Director, Ramesh Subrahmanian - Independent Director, Ravindranath Kancherla - Ind. Non-Executive Director, Venkata Lakshmana Rao Chunduru - Executive Director, Ravindranath Kancherla - Ind. Non-Executive Director.
It is listed on the BSE with a BSE Code of 540222 and the NSE with an NSE Code of LAURUSLABS.
Its Registered office is at Plot No.21 & 18, Jawaharlal Nehru Pharma City,
,Parawada, Vishakapatnam,Andhra Pradesh - 531021.
Their Registrars are Karvy Computershare Private Ltd.
Quick Links for Laurus Labs
Related Searches
Laurus Labs Stock Price, Laurus Labs Stock Quote, Laurus Labs Results , Laurus Labs News ..
More »
Follow moneycontrol
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds |
Budget 2018 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Kolkata | Online Shopping in India | Cairn India | Euro | Infosys | Inflation | Silver | Glenmark Pharmaceuticals | Snapdeal | Starbucks | Narendra Modi | Crore
| Clear Study Doubts | Education Franchisee Opportunity | Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Policy | Terms & Conditions | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
